Maze Therapeutics Inc (NAS:MAZE)
$ 25.07 +0.47 (+1.89%) Market Cap: 1.39 Bil Enterprise Value: 1.04 Bil PE Ratio: 0 PB Ratio: 3.07 GF Score: 16/100

Maze Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 03:30 PM GMT
Release Date Price: $46.48 (+5.21%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MAZE.OQ - Maze Therapeutics Inc
Maze Therapeutics Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 03:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone. Tyler Van Buren here, senior biotech analyst at TD Cowan.

Thank you very much for joining TD Cowan's forty-sixth annual healthcare conference. For our next session, very excited to have a hybrid presentation and fireside with May Therapeutics, and it's my pleasure to introduce, Jason Kaloma, the CEO of May.

Jason, it's a privilege to have you here.

Thank you for joining me. I'll hand it over to you for the presentation.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Tyler. Hi, I'm Jason Kloma, and good
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot